gp-tcm-logo

WP2 – Extraction and Component Analysis of CHM

Once we have obtained CHM with a guaranteed quality, we may have to extract and purify them for functional genomics studies. This step is indispensable to functional genomics techniques such as in vitro DNA finger-typing, microarray, activity assay, HPLC analysis and purification. If herbal drugs are to be given to animals or patients, of course, most commonly extracts but not crude herbs are used. As there are a lot of extraction and purification protocols that might lead to fundamental changes of components and function of extracts, it is crucial to inform European scientists to observe a good practice for herbal extraction and purification, which will be discussed in WP2, to maximise the opportunities for success in studies of CHM. Within this process we will need to be aware of the complex and multidimensional aspects of CHM and create protocols that do not simply identify one active …more

GP-TCM Special Issue - web - sq

The GP-TCM J. Ethnopharmacol. Special Issue

The GP-TCM J. Ethnopharmacol. Special Issue published and made …more

University of Minho - sq

The 2nd GP-TCM Annual Meeting

The 2nd Annual General Meeting (AGM) of the GP-TCM consortium took place in Braga on 21st – 24th July 2011. The meeting gathered more than 50 beneficiary as well as …more

meeting photo sq

Joint WP1-WP2 Phase III Meeting

The joint phase III meeting of WP1 and WP2 was held in Braga, Portugal on 3rd – 4th December …more

pic1

WP1 and WP2 Joint Phase II Meeting

The joint Phase II meeting of WP1 and WP2 brought together 17 participants acroos Europe and China in Düsseldorf, Germany. …more